MANITOBA PRESCRIBING PRACTICES PROGRAM (M3P)
It is my intention to prescribe designated drug(s) and I will require the initial issues of multiple
prescriptions. In making this application I recognize that:
I am required to keep secure and be accountable for every prescription issued under my name.
Loss or theft of pads will be reported promptly both verbally and in writing to the Manitoba
Prescribing Practices Program (M3P).
Designated drugs can be prescribed only with the use of the multiple prescription and I have
the responsibility to re-order prescriptions.
The multiple prescription must be completed accurately, completely, and legibly to be valid.
Invalid prescriptions will not be filled.
Physician Name (Please Print)
Full Office Mailing Address
where the pads will be mailed
(This address should be your Primary
Practice Location in our database)
Application Date
Signature of Physician
Registration #
Registration Start Date
FOR OFFICE USE ONLY
Validation by Registering Body
(Authorized Signature)
Date Authorized
Input Date
Date sent to CPhM
Return application via:
EMAIL CPSMM3P@cpsm.mb.ca or FAX TO (204) 774-0750
Upon approval, this application information will be forwarded to the Manitoba Prescribing Practices Program
(M3P).
REVISION: August 2021
_________________________________________________________
click to sign
signature
click to edit
LIST OF DRUGS COVERED BY THE MANITOBA PRESCRIBING PRACTICES PROGRAM (M3P)
NOTE: All sales reportable narcotics and controlled drugs are included under the M3P Program.
WARNING: This is a reference list provided for convenience.
While all generic names appear, only sample brand names are provided. It should not be viewed as
an all-inclusive listing of brand names included under the M3P program.
AMPHETAMINES & DERIVATIVES
HYDROCODONE
NABILONE
Adderall XR
Ratio
Coristex DH
Cesamet
Dexedrine
Dimetane Expectorant DC
Dexedrine Spansule
Hycodan
NALBUPHINE
Novahistex DH & DH
Nubain
ANILERIDINE
Expectorant
Novahistine DH
NORMETHADONE
-
p
-
BUPRENORPHINE & NALOXONE
Triaminic Expectorant DH
HYDROXYEPHEDRINE
Suboxone
Tussionex
Cophylac
NOTE: May be prescribed only by
those prescribers approved by their
HYDROMORPHONE
OPIUM & BELLADONNA
regulatory authority.
Dilaudid
SAB
Opium & Belladonna
Butrans
Dilaudid HP
suppositories
Dilaudid LA
BUTALBITAL WITH OR WITHOUT
Dilaudid Powder
OXYCODONE
CODEINE
Hydromorph Contin
Endocet
Fiorinal
Hydromorph
IR
Oxycodan
Tecnal
Oxycocet
KETAMINE
(Including compounded
OxyContin
BUTORPHANOL
prescriptions containing ketamine)
Oxy
IR
Apo
Butorphanol
Percocet
PMS
Butorphanol
MEPERIDINE (PETHIDINE)
Supeudol
Demerol
COCAINE
PENTAZOCINE
METHAQUALONE
Talwin
CODEINE
(either pure or those
preparations with only 1 active
METHADONE
PENTOBARBITAL
ingredient
other than codeine)
NOTE: May be prescribed only by
Nembutal Sodium
Codeine Contin
those prescribers approved by their
Ratio
Emtec
regulatory authority.
PHENOBARBITAL WITH CODEINE
Lenoltec #4
Tylenol #4
METHYLPHENIDATE
PHENTERMINE
Tylenol
with Codeine Elixir
Ritalin
Ionamin
Foquest
DIACETYLMORPHINE
PROPOXYPHENE
NOTE: May be prescribed only by those
MORPHINE
Darvon N
prescribers approved by their regulatory
Kadian
authority.
NOTE: If for opioid replacement
SODIUM OXYBATE
therapy, may be prescribed only by
Xyrem
DIETHYLPROPION
those prescribers approved by their
Tenuate
regulatory authority.
TAPENTADOL
M
Eslon
Nucynta CR
DIPHENOXYLATE
Morphine
Lomotil
MOS
TETRAHYDROCANNABINOL
(and
MS Contin
all
derivatives of Cannabis including
FENTANYL/SUFENTANIL/ ALFENTANIL
MS
IR
synthetic preparations)
Fentanyl Patches
Statex
Marinol
Sufentanil injection
Sativex
Alfentanil injection
Revised: December 2019
*Please note that lisdexamfetamine (Vyvanse®), methylphenidate OROS (Concerta®), Methylphenidate
MLR (Biphentin®) and methylphenidate ER (Foques) are no longer on the M3P Drug List.